Beer, S.A.; Wirths, S.; Vogel, W.; Tabatabai, G.; Ernemann, U.; Merle, D.A.; Bethge, W.; Möhle, R.; Lengerke, C.
Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma. Cancers 2023, 15, 669.
https://doi.org/10.3390/cancers15030669
AMA Style
Beer SA, Wirths S, Vogel W, Tabatabai G, Ernemann U, Merle DA, Bethge W, Möhle R, Lengerke C.
Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma. Cancers. 2023; 15(3):669.
https://doi.org/10.3390/cancers15030669
Chicago/Turabian Style
Beer, Sina A., Stefan Wirths, Wichard Vogel, Ghazaleh Tabatabai, Ulrike Ernemann, David A. Merle, Wolfgang Bethge, Robert Möhle, and Claudia Lengerke.
2023. "Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma" Cancers 15, no. 3: 669.
https://doi.org/10.3390/cancers15030669
APA Style
Beer, S. A., Wirths, S., Vogel, W., Tabatabai, G., Ernemann, U., Merle, D. A., Bethge, W., Möhle, R., & Lengerke, C.
(2023). Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma. Cancers, 15(3), 669.
https://doi.org/10.3390/cancers15030669
